MANNKIND CORP (MNKD)       2.98  -0.02 (-0.67%)

2.98  -0.02 (-0.67%)

US56400P7069 - Common Stock

News Image
6 days ago - MannKind

MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
8 days ago - InvestorPlace

7 Penny Stocks That Actually Have a Buy Rating

Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.

News Image
19 days ago - Market News Video

Interesting MNKD Call Options For October 28th

News Image
21 days ago - MannKind

Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine

Study supports the dosing regimen that will be pursued in further clinical programsNo serious adverse events or QT prolongation identifiedPlanning underway...

News Image
a month ago - MannKind

MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
2 months ago - MannKind

MannKind Corporation Reports 2022 Second Quarter Financial Results

Conference Call to Begin Today at 5:00 p.m. (ET) Tyvaso DPI™ approved by the FDA in May representing the second FDA-approved product using the...

News Image
2 months ago - MannKind

MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter...

News Image
2 months ago - MannKind

MannKind Corporation to Participate in the BTIG Biotechnology Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
4 months ago - MannKind

Mannkind to Host Product Theater and Booth at the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7

WESTLAKE VILLAGE, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and...

News Image
4 months ago - Market News Video

MannKind (MNKD) Shares Cross Below 200 DMA

News Image
4 months ago - MannKind

MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™

Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...

News Image
4 months ago - MannKind

MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., May 19, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
4 months ago - MannKind

MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma

The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions DANBURY, Conn. and WESTLAKE...

News Image
5 months ago - InvestorPlace

7 Biotech Stocks With Key Catalysts for May

The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.

News Image
5 months ago - MannKind

MannKind Corporation Participating at Upcoming Conferences

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., May 09, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
5 months ago - MannKind

MannKind Corporation Reports 2022 First Quarter Financial Results

Conference Call to Begin Today at 5:00 p.m. (ET)...